Don't Just Read the News, Understand It.
Published loading...Updated

Cosette terminates $672m Mayne Pharma deal as legal challenge looms

Summary by Australian Financial Review
The private-equity backed American giant began reviewing the deal two weeks ago because of concerns about its target’s financial performance since it first bid.

Bias Distribution

  • 100% of the sources lean Right
100% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Australian Financial Review broke the news in Sydney, Australia on Wednesday, June 4, 2025.
Sources are mostly out of (0)